Teladoc Health (NYSE:TDOC) Price Target Cut to $12.00 by Analysts at Oppenheimer

Teladoc Health (NYSE:TDOC) had its price objective cut by Oppenheimer from $14.00 to $12.00 in a report released on Friday,Benzinga reports. They currently have an outperform rating on the health services provider’s stock.

A number of other brokerages also recently commented on TDOC. TD Cowen decreased their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Barclays lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a research note on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective for the company. Royal Bank of Canada lifted their target price on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Finally, Evercore ISI increased their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $12.08.

Teladoc Health Stock Down 0.8 %

Shares of NYSE:TDOC opened at $10.06 on Friday. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock’s 50-day moving average is $10.01 and its 200-day moving average is $9.04. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $21.74.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. The firm had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, sell-side analysts forecast that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Large investors have recently made changes to their positions in the company. Versant Capital Management Inc lifted its stake in Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 2,441 shares in the last quarter. Blue Trust Inc. grew its stake in Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares in the last quarter. Doheny Asset Management CA acquired a new position in shares of Teladoc Health during the 2nd quarter worth approximately $46,000. Benjamin F. Edwards & Company Inc. raised its stake in shares of Teladoc Health by 209.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after purchasing an additional 3,396 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Teladoc Health by 194.2% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider’s stock valued at $67,000 after buying an additional 4,549 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.